182 related articles for article (PubMed ID: 30086361)
1. Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB.
He R; Shi X; Zhou M; Zhao Y; Pan S; Zhao C; Guo X; Wang M; Li X; Qin R
Toxicol Appl Pharmacol; 2018 Oct; 356():159-171. PubMed ID: 30086361
[TBL] [Abstract][Full Text] [Related]
2. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
[TBL] [Abstract][Full Text] [Related]
3. Active ingredients of
Yan YY; Zhang Q; Zhang B; Yang B; Lin NM
Nat Prod Res; 2020 Sep; 34(17):2539-2544. PubMed ID: 30661396
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of alantolactone in lung cancer cell lines NCI-H1299 and Anip973.
Liu J; Yang Z; Kong Y; He Y; Xu Y; Cao X
J Food Biochem; 2019 Sep; 43(9):e12972. PubMed ID: 31489665
[TBL] [Abstract][Full Text] [Related]
5. Alantolactone induces apoptosis in RKO cells through the generation of reactive oxygen species and the mitochondrial pathway.
Zhang Y; Bao YL; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
Mol Med Rep; 2013 Oct; 8(4):967-72. PubMed ID: 23970102
[TBL] [Abstract][Full Text] [Related]
6. Alantolactone induces apoptosis in glioblastoma cells via GSH depletion, ROS generation, and mitochondrial dysfunction.
Khan M; Yi F; Rasul A; Li T; Wang N; Gao H; Gao R; Ma T
IUBMB Life; 2012 Sep; 64(9):783-94. PubMed ID: 22837216
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways.
He Y; Cao X; Kong Y; Wang S; Xia Y; Bi R; Liu J
Hum Exp Toxicol; 2019 Oct; 38(10):1132-1144. PubMed ID: 31203647
[TBL] [Abstract][Full Text] [Related]
8. 6-Hydroxydopamine induces autophagic flux dysfunction by impairing transcription factor EB activation and lysosomal function in dopaminergic neurons and SH-SY5Y cells.
He X; Yuan W; Li Z; Hou Y; Liu F; Feng J
Toxicol Lett; 2018 Feb; 283():58-68. PubMed ID: 29170033
[TBL] [Abstract][Full Text] [Related]
9. Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion.
Wei W; Huang H; Zhao S; Liu W; Liu CX; Chen L; Li JM; Wu YL; Yan H
Apoptosis; 2013 Sep; 18(9):1060-70. PubMed ID: 23613107
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction by alantolactone in breast cancer MDA-MB-231 cells through reactive oxygen species-mediated mitochondrion-dependent pathway.
Cui L; Bu W; Song J; Feng L; Xu T; Liu D; Ding W; Wang J; Li C; Ma B; Luo Y; Jiang Z; Wang C; Chen J; Hou J; Yan H; Yang L; Jia X
Arch Pharm Res; 2018 Mar; 41(3):299-313. PubMed ID: 29214600
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of oxaliplatin-induced colon cancer cell apoptosis by alantolactone, a natural product inducer of ROS.
Cao P; Xia Y; He W; Zhang T; Hong L; Zheng P; Shen X; Liang G; Cui R; Zou P
Int J Biol Sci; 2019; 15(8):1676-1684. PubMed ID: 31360110
[TBL] [Abstract][Full Text] [Related]
12. Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.
Yao Y; Xia D; Bian Y; Sun Y; Zhu F; Pan B; Niu M; Zhao K; Wu Q; Qiao J; Fu C; Li Z; Xu K
Apoptosis; 2015 Aug; 20(8):1122-33. PubMed ID: 26033479
[TBL] [Abstract][Full Text] [Related]
13. Curcumin targets the TFEB-lysosome pathway for induction of autophagy.
Zhang J; Wang J; Xu J; Lu Y; Jiang J; Wang L; Shen HM; Xia D
Oncotarget; 2016 Nov; 7(46):75659-75671. PubMed ID: 27689333
[TBL] [Abstract][Full Text] [Related]
14. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
15. Induction of ROS Overload by Alantolactone Prompts Oxidative DNA Damage and Apoptosis in Colorectal Cancer Cells.
Ding Y; Wang H; Niu J; Luo M; Gou Y; Miao L; Zou Z; Cheng Y
Int J Mol Sci; 2016 Apr; 17(4):558. PubMed ID: 27089328
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
He W; Cao P; Xia Y; Hong L; Zhang T; Shen X; Zheng P; Shen H; Zhao Y; Zou P
Free Radic Res; 2019 Jan; 53(1):104-114. PubMed ID: 30668191
[TBL] [Abstract][Full Text] [Related]
17. Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone.
Rasul A; Khan M; Ali M; Li J; Li X
ScientificWorldJournal; 2013; 2013():248532. PubMed ID: 24288468
[TBL] [Abstract][Full Text] [Related]
18. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress.
Maryam A; Mehmood T; Zhang H; Li Y; Khan M; Ma T
Sci Rep; 2017 Jul; 7(1):6242. PubMed ID: 28740138
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting ROS-TFEB-Dependent Autophagy Enhances Salidroside-Induced Apoptosis in Human Chondrosarcoma Cells.
Zeng W; Xiao T; Cai A; Cai W; Liu H; Liu J; Li J; Tan M; Xie L; Liu Y; Yang X; Long Y
Cell Physiol Biochem; 2017; 43(4):1487-1502. PubMed ID: 29035891
[TBL] [Abstract][Full Text] [Related]
20. Alantolactone inhibits growth of K562/adriamycin cells by downregulating Bcr/Abl and P-glycoprotein expression.
Yang C; Yang J; Sun M; Yan J; Meng X; Ma T
IUBMB Life; 2013 May; 65(5):435-44. PubMed ID: 23441067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
